A citation-based method for searching scientific literature

Mary Linton Peters, Judy E Garber, Nadine Tung. Gynecol Oncol 2017
Times Cited: 7







List of co-cited articles
19 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Prognostic value of vascular endothelial growth factor (VEGF) in head and neck squamous cell carcinomas.
H Mineta, K Miura, T Ogino, S Takebayashi, K Misawa, Y Ueda, I Suzuki, M Dictor, A Borg, J Wennerberg. Br J Cancer 2000
108
14



Phase I study of bevacizumab added to fluorouracil- and hydroxyurea-based concomitant chemoradiotherapy for poor-prognosis head and neck cancer.
Tanguy Y Seiwert, Daniel J Haraf, Ezra E W Cohen, Kerstin Stenson, Mary Ellyn Witt, Allison Dekker, Masha Kocherginsky, Ralph R Weichselbaum, Helen X Chen, Everett E Vokes. J Clin Oncol 2008
108
14

The host STING pathway at the interface of cancer and immunity.
Leticia Corrales, Sarah M McWhirter, Thomas W Dubensky, Thomas F Gajewski. J Clin Invest 2016
180
14

STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors.
Seng-Ryong Woo, Mercedes B Fuertes, Leticia Corrales, Stefani Spranger, Michael J Furdyna, Michael Y K Leung, Ryan Duggan, Ying Wang, Glen N Barber, Katherine A Fitzgerald,[...]. Immunity 2014
717
14

Low incidence of mutations in EGFR kinase domain in Caucasian patients with head and neck squamous cell carcinoma.
Judith Loeffler-Ragg, Martina Witsch-Baumgartner, Alexandar Tzankov, Wolgang Hilbe, Ilona Schwentner, Georg M Sprinzl, Gerd Utermann, Heinz Zwierzina. Eur J Cancer 2006
127
14

Toxicities of systemic agents in squamous cell carcinoma of the head and neck (SCCHN); A new perspective in the era of immunotherapy.
Nabil F Saba, Mayur D Mody, Elaine S Tan, Harpaul S Gill, Alessandra Rinaldo, Robert P Takes, Primož Strojan, Dana M Hartl, Jan B Vermorken, Missak Haigentz,[...]. Crit Rev Oncol Hematol 2017
23
14

Targeting the PI3K/AKT/mTOR pathway in squamous cell carcinoma of the head and neck.
Daniel R Simpson, Loren K Mell, Ezra E W Cohen. Oral Oncol 2015
87
14

Molecular Imaging and Precision Medicine in Head and Neck Cancer.
Esther Mena, Shwetha Thippsandra, Anusha Yanamadala, Siddaling Redy, Puskar Pattanayak, Rathan M Subramaniam. PET Clin 2017
7
14

[Modalities for the functionning of a Care Center for women at high risk for breast and ovarian cancers: The French experience of Tenon Hospital].
N Chabbert-Buffet, B Seroussi, J Chopier, A Fajac, M Antoine, C Boucher, C Colas, B Belaroussi, C Waserman, M-O Deschamps,[...]. Gynecol Obstet Fertil 2010
2
50




[Clinical and molecular diagnosis of inherited breast-ovarian cancer].
A Chompret. J Gynecol Obstet Biol Reprod (Paris) 2003
4
25

[Identification and management of hereditary predisposition to cancer of the breast and the ovary (update 2004)].
François Eisinger, Brigitte Bressac, Damienne Castaigne, Pierre-Henri Cottu, Jacques Lansac, Jean-Pierre Lefranc, Anne Lesur, Catherine Noguès, Janine Pierret, Séverine Puy-Pernias,[...]. Bull Cancer 2004
90
14

Cost-effectiveness of risk-reducing surgeries in preventing hereditary breast and ovarian cancer.
Michael G Schrauder, Lisa Brunel-Geuder, Lothar Häberle, Marius Wunderle, Juliane Hoyer, André Reis, Rüdiger Schulz-Wendtland, Matthias W Beckmann, Michael P Lux. Breast 2017
16
14

Are synchronous and metachronous bilateral breast cancers different? An immunohistochemical analysis aimed at intrinsic tumor phenotype.
Elżbieta Senkus, Jolanta Szade, Beata Pieczyńska, Anna Zaczek, Joanna Pikiel, Katarzyna Sosińska-Mielcarek, Agnieszka Karpińska, Jacek Jassem. Int J Clin Exp Pathol 2013
9
14

Effects of BRCA1- and BRCA2-related mutations on ovarian and breast cancer survival: a meta-analysis.
Qian Zhong, Hong-Ling Peng, Xia Zhao, Lin Zhang, Wei-Ting Hwang. Clin Cancer Res 2015
102
14

Patterns and progress in ovarian cancer over 14 years.
John K Chan, Michael K Cheung, Amreen Husain, Nelson N Teng, Dee West, Alice S Whittemore, Jonathan S Berek, Kathryn Osann. Obstet Gynecol 2006
109
14

Carcinoma of the ovary. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer.
A P M Heintz, F Odicino, P Maisonneuve, M A Quinn, J L Benedet, W T Creasman, H Y S Ngan, S Pecorelli, U Beller. Int J Gynaecol Obstet 2006
513
14

Management of Breast Cancer Risk in Women with Ovarian Cancer and Deleterious BRCA1 or BRCA2 Mutations.
Andrea E Wahner Hendrickson, Jamie N Bakkum-Gamez, Fergus J Couch, Karthik Ghosh, Judy C Boughey. Ann Surg Oncol 2017
2
50

Cancer Statistics, 2017.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2017
14

Conditional survival in ovarian cancer: results from the SEER dataset 1988-2001.
Mehee Choi, Clifton D Fuller, Charles R Thomas, Samuel J Wang. Gynecol Oncol 2008
88
14

Ovarian cancer in younger vs older women: a population-based analysis.
J K Chan, R Urban, M K Cheung, K Osann, J Y Shin, A Husain, N N Teng, D S Kapp, J S Berek, G S Leiserowitz. Br J Cancer 2006
90
14

Cancer treatment and survivorship statistics, 2014.
Carol E DeSantis, Chun Chieh Lin, Angela B Mariotto, Rebecca L Siegel, Kevin D Stein, Joan L Kramer, Rick Alteri, Anthony S Robbins, Ahmedin Jemal. CA Cancer J Clin 2014
14

Delivering widespread BRCA testing and PARP inhibition to patients with ovarian cancer.
Angela George, Stan Kaye, Susana Banerjee. Nat Rev Clin Oncol 2017
88
14

Breast cancer statistics, 2017, racial disparity in mortality by state.
Carol E DeSantis, Jiemin Ma, Ann Goding Sauer, Lisa A Newman, Ahmedin Jemal. CA Cancer J Clin 2017
794
14

Epidemiologic pathology of ovarian cancer from the Vaud Cancer Registry, Switzerland.
F Levi, S Franceschi, C La Vecchia, J Ruzicka, E Gloor, L Randimbison. Ann Oncol 1993
31
14

Long-term results and prognostic factors in patients with epithelial ovarian cancer.
J L Brun, A Feyler, G Chêne, J Saurel, G Brun, C Hocké. Gynecol Oncol 2000
101
14




Clinical management of breast cancer heterogeneity.
Dimitrios Zardavas, Alexandre Irrthum, Charles Swanton, Martine Piccart. Nat Rev Clin Oncol 2015
234
14

Comparative N-Glycosylation Analysis of the Fc Portions of a Chimeric Human Coagulation Factor VIII and Immunoglobulin G1.
Christoph Kannicht, Mario Kröning, Barbara A Solecka-Witulska, Guido Kohla, Julia Rosenlöcher. Bioengineering (Basel) 2017
4
25

Dense genomic sampling identifies highways of pneumococcal recombination.
Claire Chewapreecha, Simon R Harris, Nicholas J Croucher, Claudia Turner, Pekka Marttinen, Lu Cheng, Alberto Pessia, David M Aanensen, Alison E Mather, Andrew J Page,[...]. Nat Genet 2014
231
14

Apoptosis of lung cancer cells caused by some anti-cancer agents (MMC, CPT-11, ADM) is inhibited by bcl-2.
T Ohmori, E R Podack, K Nishio, M Takahashi, Y Miyahara, Y Takeda, N Kubota, Y Funayama, H Ogasawara, T Ohira. Biochem Biophys Res Commun 1993
169
14

Humanization of an anti-p185HER2 antibody for human cancer therapy.
P Carter, L Presta, C M Gorman, J B Ridgway, D Henner, W L Wong, A M Rowland, C Kotts, M E Carver, H M Shepard. Proc Natl Acad Sci U S A 1992
14

Combining lapatinib and pertuzumab to overcome lapatinib resistance due to NRG1-mediated signalling in HER2-amplified breast cancer.
Wing-yin Leung, Ioannis Roxanis, Helen Sheldon, Francesca M Buffa, Ji-liang Li, Adrian L Harris, Anthony Kong. Oncotarget 2015
24
14

Vinca alkaloids.
Maryam Moudi, Rusea Go, Christina Yong Seok Yien, Mohd Nazre. Int J Prev Med 2013
134
14

RUNX3 is frequently inactivated by dual mechanisms of protein mislocalization and promoter hypermethylation in breast cancer.
Quek Choon Lau, Erna Raja, Manuel Salto-Tellez, Qiang Liu, Kosei Ito, Masafumi Inoue, Thomas Choudary Putti, Marie Loh, Tun Kiat Ko, Canhua Huang,[...]. Cancer Res 2006
155
14


Signaling cross-talk in the resistance to HER family receptor targeted therapy.
H Yamaguchi, S-S Chang, J L Hsu, M-C Hung. Oncogene 2014
80
14

Liposomal drug delivery systems: from concept to clinical applications.
Theresa M Allen, Pieter R Cullis. Adv Drug Deliv Rev 2013
14



Cell killing by antibody-drug conjugates.
Yelena V Kovtun, Victor S Goldmacher. Cancer Lett 2007
121
14

Phase I clinical study of pertuzumab, a novel HER dimerization inhibitor, in patients with advanced cancer.
David B Agus, Michael S Gordon, Charles Taylor, Ronald B Natale, Beth Karlan, David S Mendelson, Michael F Press, David E Allison, Mark X Sliwkowski, Gracie Lieberman,[...]. J Clin Oncol 2005
287
14


Targeted therapy in breast cancer: what's new?
Lei Fang, Zeinab Barekati, Bei Zhang, Zhiyong Liu, Xiaoyan Zhong. Swiss Med Wkly 2011
28
14


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.